Join Shares Magazine and AJ Bell Media for the next Shares Spotlight webinar on Thursday 14 May 2020 which can be accessed from wherever you are!
The webinar will feature the following companies:
Diurnal (DNL) is a specialty pharmaceutical company developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.
Open Orphan (ORPH) goal is to become Europe’s leading rare disease and orphan drug focused pharma services company. Its management team have extensive industry and financial expertise.
And more companies to be announced!
Go here for further details and to register